Imfinzi Durvalumab

Fact of Medicine

  • Brand Name: Imfinzi
  • Innovator Brand Name: Imfinzi
  • API: Durvalumab
  • Packaging: 1 Vial (Per Box)
  • Strength: 120mg/500mg
  • Manufacturer Name: Astrazeneca
Get Price

Description

Uses of medication: Imfinzi (Durvalumab) is (PD-L1) blocking antibody used for the treatment of patients with:

  • Metastatic Urothelial Carcinoma
  • Non-Small Cell Lung Cancer

Dosage: The recommended durvalumab dose is 10 mg/kg, which should be administered as an intravenous infusion over 60 minutes every 2 weeks, until the disease progression or unacceptable toxicity.

Treatment Reactions: The commonly reported imfinzi side effects in patients with urothelial carcinoma include: fatigue, musculoskeletal pain, constipation, nausea, peripheral edema, decreased appetite and urinary tract infection.

The commonly reported imfinzi side effects in patients with non-Small Cell Lung Cancer include cough, fatigue, pneumonitis/radiation pneumonitis, dyspnea, upper respiratory tract infections, and rash.

Warnings and Precautions:

  • Patients should be monitored for the signs/symptoms of hepatitis, during and following the discontinuation of imfinzi 500mg therapy.
  • Patients should be monitored for thyroid function before and periodically during durvalumab 120 mg treatment.
  • Patients should be monitored for the abnormal renal function tests before and periodically during durvalumab treatment.
  • Patients receiving treatment with Imfinzi injection 500 mg should be monitored for hyperglycemia or other signs/symptoms of diabetes.
  • Women with childbearing potential and receiving durvalumab lung cancer drug, should avoid becoming pregnant.

More Info.

Storage: Store Imfinzi (durvalumab) injection in a refrigerator at temperature 2°C to 8°C (36°F to 46°F) in the original carton in order to protect from light. Neither freeze nor shake the medication.

Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship IMFINZI at the global level as per the need of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the IMFINZI Injections.

Buying Procedure: In order to buy IMFINZI, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919650877511 or an Email to us at: info@theindianpharma.com along with your ID Proof, Valid Prescription Letter and Medical Reports.

Commonly Asked Questions

What does Imfinzi contain as an active substance?

The medication Imfinzi specifically contains the active substance Durvalumab.

From which class of drug Durvalumab belongs?

Durvalumab basically belongs to a class of drugs named monoclonal antibodies.

How does Durvalumab act?

Durvalumab acts in order to block the activity of PDL-1, a specific molecule that exists on T-cells that suppresses the immune activity. In order to block the PDL-1, T-cells function better and the immune response is stimulated to find and destroy cancer cells.

How much does imfinzi cost?

The imfinzi price in India may vary depending on the wholesaler/pharmacy you visit. Cost for the Imfinzi 50 mg/mL is around 67,824 INR for a supply of 2.4 milliliters.

Where can I get Durvalumab at the best price?

In order to get the best durvalumab price, always buy this medication from a such Pharmaceutical Wholesaler Company which is ISO and WHO-GDP certified.

Can I get Durvalumab (Imfinzi) even if I am not based in India?

The Indian Pharma helps patients in accessing or importing Durvalumab (Imfinzi), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.

Send your inquiry to find Imfinzi (durvalumab) Capsules in UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia, Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.

×